Authors' Reply to Ganijee et al.: "Comment on: Evaluation of the Influence of Sildenafil on Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Vericiguat in Healthy Adults".

Saved in:
Bibliographic Details
Title: Authors' Reply to Ganijee et al.: "Comment on: Evaluation of the Influence of Sildenafil on Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Vericiguat in Healthy Adults".
Authors: Boettcher M; Clinical Pharmacology, Bayer AG, Research & Development, Building 0520, 42096, Wuppertal, Germany., Becker C; Clinical Pharmacology, Bayer AG, Research & Development, Building 0520, 42096, Wuppertal, Germany. corina.becker@bayer.com.
Source: Clinical pharmacokinetics [Clin Pharmacokinet] 2023 Nov; Vol. 62 (11), pp. 1651-1653. Date of Electronic Publication: 2023 Sep 26.
Publication Type: Letter; Comment
Journal Info: Publisher: Adis, part of Springer Science+Business Media Country of Publication: Switzerland NLM ID: 7606849 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1926 (Electronic) Linking ISSN: 03125963 NLM ISO Abbreviation: Clin Pharmacokinet Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1179-1926
DOI:10.1007/s40262-023-01304-9